Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 42, Issue 7 (June 2017) In this issue Editorial Commentary Review Article Original Articles In Memoriam Corrigenda Also new AOP Facebook Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top NPP: Our Designs for the Future William A Carlezon, Jr and Anissa Abi-Dargham Neuropsychopharmacology 2017 42: 1371-1372; 10.1038/npp.2017.54 Full Text Commentary Top Will Viewing Overeating as Compulsive Lead to Novel Pharmacological Interventions? Kristin N Javaras Neuropsychopharmacology 2017 42: 1373-1374; advance online publication, January 6, 2017; 10.1038/npp.2017.29 Full Text Review Article Top Pathological Overeating: Emerging Evidence for a Compulsivity Construct Catherine F Moore, Valentina Sabino, George F Koob and Pietro Cottone Neuropsychopharmacology 2017 42: 1375-1389; advance online publication, December 6, 2016; 10.1038/npp.2016.269 Abstract | Full Text Original Articles Top Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial Jeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Mark F Bear, Paul P Wang and Randall L Carpenter Neuropsychopharmacology 2017 42: 1390-1398; advance online publication, October 17, 2016; 10.1038/npp.2016.237 Abstract | Full Text Differential Abnormal Pattern of Anterior Cingulate Gyrus Activation in Unipolar and Bipolar Depression: an fMRI and Pattern Classification Approach Christian Bürger, Ronny Redlich, Dominik Grotegerd, Susanne Meinert, Katharina Dohm, Ilona Schneider, Dario Zaremba, Katharina Förster, Judith Alferink, Jens Bölte, Walter Heindel, Harald Kugel, Volker Arolt and Udo Dannlowski Neuropsychopharmacology 2017 42: 1399-1408; advance online publication, February 16, 2017; 10.1038/npp.2017.36 Abstract | Full Text Effects of Oxytocin and Vasopressin on Preferential Brain Responses to Negative Social Feedback Marta Gozzi, Erica M Dashow, Audrey Thurm, Susan E Swedo and Caroline F Zink Neuropsychopharmacology 2017 42: 1409-1419; advance online publication, October 31, 2016; 10.1038/npp.2016.248 Abstract | Full Text Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates Alberto Galbusera, Alessia De Felice, Stefano Girardi, Giacomo Bassetto, Marta Maschietto, Katsuhiko Nishimori, Bice Chini, Francesco Papaleo, Stefano Vassanelli and Alessandro Gozzi Neuropsychopharmacology 2017 42: 1420-1434; advance online publication, December 20, 2016; 10.1038/npp.2016.283 Abstract | Full Text Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression OPEN Gurudutt Pendyala, Shinnyi Chou, Yoosun Jung, Pierluca Coiro, Elizabeth Spartz, Ragunathan Padmashri, Ming Li and Anna Dunaevsky Neuropsychopharmacology 2017 42: 1435-1446; advance online publication, January 19, 2017; 10.1038/npp.2017.7 Abstract | Full Text Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model Ashleigh L Osborne, Nadia Solowij, Ilijana Babic, Xu-Feng Huang and Katrina Weston-Green Neuropsychopharmacology 2017 42: 1447-1457; advance online publication, February 23, 2017; 10.1038/npp.2017.40 Abstract | Full Text The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats Antonio Ferragud, Adam D Howell, Catherine F Moore, Tina L Ta, Marius C Hoener, Valentina Sabino and Pietro Cottone Neuropsychopharmacology 2017 42: 1458-1470; advance online publication, October 6, 2016; 10.1038/npp.2016.233 Abstract | Full Text Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control Amber L Alhadeff, Blake D Mergler, Derek J Zimmer, Christopher A Turner, David J Reiner, Heath D Schmidt, Harvey J Grill and Matthew R Hayes Neuropsychopharmacology 2017 42: 1471-1479; advance online publication, October 26, 2016; 10.1038/npp.2016.246 Abstract | Full Text Obesity-Induced Structural and Neuronal Plasticity in the Lateral Orbitofrontal Cortex Jennifer L Thompson, Michael Drysdale, Corey Baimel, Manpreet Kaur, Taigan MacGowan, Kimberley A Pitman and Stephanie L Borgland Neuropsychopharmacology 2017 42: 1480-1490; advance online publication, January 2, 2017; 10.1038/npp.2016.284 Abstract | Full Text Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain Alessandro Rimessi, Chiara Pavan, Elli Ioannidi, Federica Nigro, Claudia Morganti, Alberto Brugnoli, Francesco Longo, Chiara Gardin, Letizia Ferroni, Michele Morari, Vincenzo Vindigni, Barbara Zavan and Paolo Pinton Neuropsychopharmacology 2017 42: 1491-1501; advance online publication, January 27, 2017; 10.1038/npp.2017.20 Abstract | Full Text The Role of The RNA Demethylase FTO (Fat Mass and Obesity-Associated) and mRNA Methylation in Hippocampal Memory Formation Brandon J Walters, Valentina Mercaldo, Colleen J Gillon, Matthew Yip, Rachael L Neve, Frederick M Boyce, Paul W Frankland and Sheena A Josselyn Neuropsychopharmacology 2017 42: 1502-1510; advance online publication, February 16, 2017; 10.1038/npp.2017.31 Abstract | Full Text Activation of Ventral Tegmental Area 5-HT2C Receptors Reduces Incentive Motivation OPEN Lourdes Valencia-Torres, Cristian M Olarte-Sánchez, David J Lyons, Teodora Georgescu, Megan Greenwald-Yarnell, Martin G Myers, Jr, Christopher M Bradshaw and Lora K Heisler Neuropsychopharmacology 2017 42: 1511-1521; advance online publication, November 24, 2016; 10.1038/npp.2016.264 Abstract | Full Text Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys William S John, Thomas J Martin and Michael A Nader Neuropsychopharmacology 2017 42: 1522-1530; advance online publication, January 6, 2017; 10.1038/npp.2017.2 Abstract | Full Text Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys Maylen Perez Diaz, Monica L Andersen, Kenner C Rice and Leonard L Howell Neuropsychopharmacology 2017 42: 1531-1538; advance online publication, December 16, 2016; 10.1038/npp.2016.280 Abstract | Full Text Amphetamine and Methamphetamine Increase NMDAR-GluN2B Synaptic Currents in Midbrain Dopamine Neurons Ming-Hua Li, Suzanne M Underhill, Cheryl Reed, Tamara J Phillips, Susan G Amara and Susan L Ingram Neuropsychopharmacology 2017 42: 1539-1547; advance online publication, December 15, 2016; 10.1038/npp.2016.278 Abstract | Full Text RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States Sevasti Gaspari, Valeria Cogliani, Lefteris Manouras, Ethan M Anderson, Vasiliki Mitsi, Kleopatra Avrampou, Fiona B Carr and Venetia Zachariou Neuropsychopharmacology 2017 42: 1548-1556; advance online publication, January 11, 2017; 10.1038/npp.2017.4 Abstract | Full Text In Memoriam Top Thomas Hanlon William T Carpenter Neuropsychopharmacology 2017 42: 1557; 10.1038/npp.2017.3 Full Text Corrigenda Top Memories of Opiate Withdrawal Emotional States Correlate with Specific Gamma Oscillations in the Nucleus Accumbens Cyril Dejean, Mathieu Sitko, Paul Girardeau, Amine Bennabi, Stéphanie Caillé, Martine Cador, Thomas Boraud and Catherine Le Moine Neuropsychopharmacology 2017 42: 1558; 10.1038/npp.2017.46 Full Text Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence Anna Murphy, Liam J Nestor, John McGonigle, Louise Paterson, Venkataramana Boyapati, Karen D Ersche, Remy Flechais, Shankar Kuchibatla, Antonio Metastasio, Csaba Orban, Filippo Passetti, Laurence Reed, Dana Smith, John Suckling, Eleanor Taylor, Trevor WR Obbins, Anne Lingford-Hughes, David J Nutt, John FW Deakin, Rebecca Elliott and ICCAM Platform Neuropsychopharmacology 2017 42: 1559; 10.1038/npp.2017.47 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.